- Disease: Acute COVID-19
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Retrospective
- Objective: To explore the real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir administered to outpatients diagnosed with COVID-19 who were at high risk of developing severe disease, particularly in regards to risk of hospitalisation and death in comparison to age-matched control groups
- Number of participants enrolled: 8480
- Study enrolling from to
- Study includes follow-up for 35 days
Study Data
- Elderly (≥65 years)
- Fragile population
- Outpatient clinic
- Community
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Molnupiravir
External Links
Other information
Funders/Sponsors:
- National Public Health Organization of Greece
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to